
Elite Pharmaceuticals
Elite Pharmaceuticals innovates and manufactures controlled-release pharmaceuticals, specializing in pain management.
- 53
- Public
Elite Pharmaceuticals, founded with a mission to innovate in the pharmaceutical sector, focuses on developing and manufacturing controlled-release and niche generic pharmaceuticals. The company is committed to creating abuse-deterrent opioids to combat drug misuse and abuse. Their product portfolio includes pain management solutions and therapeutic agents for cardiovascular, antidiabetic, and anti-infective treatments.
Key figures in Elite Pharmaceuticals include a team of experienced researchers and developers in the pharmaceutical industry. The company has achieved significant milestones with its proprietary abuse-deterrent technology, which is applicable to all opioids. This innovation has positioned Elite Pharmaceuticals as a crucial player in addressing opioid abuse, contributing positively to public health and safety.
Similar Companies

Acura Pharmaceuticals
acurapharm.com
Mirata Pharmaceuticals
Protect Pharmaceutical
protectpharm.com

Elite Clinical Network

New Haven Pharmaceuticals

Elysium Therapeutics
elysiumrx.com
Manhattan Pharmaceuticals

Charleston Laboratories
charlestonlabs.com

Fidelis Pharmaceuticals
fidelisrx.com

Bridge Therapeutics

AcelRx Pharmaceuticals
Royal Emerald Pharmaceuticals
royalemeraldrx.com

PleoPharma
pleopharma.com

Assertio Holdings

Tremeau Pharmaceuticals
Quick Facts
Who are Elite Pharmaceuticals' competitors?
Companies similar to Elite Pharmaceuticals include Acura Pharmaceuticals, Mirata Pharmaceuticals, Protect Pharmaceutical and Elite Clinical Network.
When was Elite Pharmaceuticals founded?
Elite Pharmaceuticals was founded in 1996.
Where is Elite Pharmaceuticals' headquarters located?
Elite Pharmaceuticals' headquarters is located in Northvale, NJ, US.
When was Elite Pharmaceuticals' last funding round?
Elite Pharmaceuticals' most recent funding round was for $500k (USD) in July 2020.
How much disclosed funding has Elite Pharmaceuticals raised?
As of Jul 13, 2020, Elite Pharmaceuticals has disclosed funding of $7.5M (USD). Undisclosed round amounts are excluded.
How many employees does Elite Pharmaceuticals have?
Elite Pharmaceuticals has 53 employees as of Feb 6, 2024.
Classification
- Ownership
- Technology
- Geographic Exposure
- Customer
- Main Product
- Tags
- Ticker
- ELTP
- SEC CIK
- 0001053369
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 2800Chemicals And Allied Products
- 2830Drugs
- 2834Pharmaceutical Preparations
- ISIC
- 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SIC
- 4000Railroad Transportation
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research
- ISIC
- 7210Research and experimental development on natural sciences and engineering